Adjust to Target in Type 2 Diabetes

Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine

  1. Richard M. Bergenstal, MD1,
  2. Mary Johnson, RN, CDE1,
  3. Margaret A. Powers, PHD, RD, CDE1,
  4. Alan Wynne, MD2,
  5. Aleksandra Vlajnic, MD3,
  6. Priscilla Hollander, MD4 and
  7. Marc Rendell, MD5
  1. 1International Diabetes Center at Park Nicollet, Minneapolis, Minnesota
  2. 2Cotton-O'Neil Clinic, Topeka, Kansas
  3. 3sanofi-aventis US, Bridgewater, New Jersey
  4. 4Baylor Endocrine Center, Dallas Texas
  5. 5Creighton Diabetes Center, Omaha, Nebraska
  1. Corresponding author: Richard M. Bergenstal, richard.bergenstal{at}parknicollet.com

Abstract

OBJECTIVE—Carbohydrate counting is an effective approach to mealtime insulin adjustment in type 1 diabetes but has not been rigorously assessed in type 2 diabetes. We sought to compare an insulin-to-carbohydrate ratio with a simple algorithm for adjusting the dose of prandial insulin glusiline.

RESEARCH AND DESIGN METHODS—This 24-week, multicenter, randomized, controlled study compared two algorithms for adjusting mealtime (glulisine) insulin along with a standard algorithm for adjusting background (glargine) insulin in 273 intent-to-treat patients with type 2 diabetes. Glulisine and glargine were adjusted weekly in both groups based on self-monitored blood glucose (SMBG) results from the previous week. The simple algorithm group was provided set doses of glulisine to take before each meal. The carbohydrate counting (carb count) group was provided an insulin-to-carbohydrate ratio to use for each meal and adjusted their glulisine dose based on the amount of carbohydrate consumed.

RESULTS—A1C levels at week 24 were 6.70% (simple algorithm) and 6.54% (carb count). The respective mean A1C changes from baseline to 24 weeks were −1.46 and −1.59% (P = 0.24). A1C <7.0% was achieved by 73.2% (simple algorithm) and 69.2% (carb count) (P = 0.70) of subjects; respective values for A1C <6.5% were 44.3 and 49.5% (P = 0.28). The total daily dose of insulin was lower, and there was a trend toward less weight gain in carb count group patients. Severe hypoglycemia rates were low and equal in the two groups.

CONCLUSIONS—Weekly basal-bolus insulin adjustments based on premeal and bedtime glucose patterns resulted in significant reductions in A1C. Having two effective approaches to delivering and adjusting rapid-acting mealtime insulin may increase physicians' and patients' willingness to advance therapy to a basal-bolus insulin regimen.

Footnotes

  • Published ahead of print at http://care.diabetesjournals.org on 25 March 2008.

    Clinical trial reg. no. NCT00135057, clinicaltrials.gov.

    R.M.B. receives grant funds from, serves on an advisory panel for, and is a consultant for sanofi-aventis. All financial compensation goes to Park Nicollet for research and education. P.H. receives grant funds from and serves on the speakers bureau and advisory panel for sanofi-aventis.

    Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

    See accompanying editorial, p. 1467.

    • Accepted March 13, 2008.
    • Received November 6, 2007.
« Previous | Next Article »Table of Contents